Jeffrey L. Ives

Jeffrey L. Ives is a declared insider at 2 companies (board member); the most frequent names are Tvardi Therapeutics, Inc. and Acumen Pharmaceuticals, Inc. Between 4 June 2019 and 3 June 2026, the trades on record add up to 41 filings.

On the market, this insider has only sold: 18 sales, €954k in total. Outside the open market, there are 9 share grants and 14 option exercises.

The record was last updated on 5 June 2026 with a share grant in Acumen Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.